Site icon FIN.

FCA review: terminal illness benefits in life insurance products

FCA has published the findings from its review of terminal illness benefits within life insurance protection products. A terminal illness benefit provides an early lump sum pay-out of a life insurance policy where the insured is diagnosed with a terminal illness and is expected to die within 12 months. Customers seeking to make terminal illness claims are therefore likely to be extremely vulnerable and may need additional support from their insurer.

FCA was made aware of cases where such customers experienced unfair outcomes. It therefore launched a review to consider life insurers’ practices alongside Consumer Duty implementation to assess whether they were acting to deliver good customer outcomes in respect of terminal illness benefits. Whilst FCA did not find anything to suggest that firms are routinely delivering poor customer outcomes for terminal illness benefits, it did highlight opportunities for improvement and the FCA’s expectations in the following key areas. The review also sets out examples of good practice:

FCA expects all life insurance manufacturers and distributors to consider the findings and take immediate action where they fall short of FCA requirements.

Exit mobile version